NorthWest Biotherapeutics Inc (NWBO)

[abc1212]

Lykiri, this is truly fanatastic news for the future of GBM treatment.

We have a final group of 108 patients who had their surgery between September 2014 and August 2015. We all know that this is a group of sicker patients. The Germans halved their white blood cell count criteria in the DCVax trial. 83 patients are treatment and 25 are placebo.(83 +25=108)(IMO)

At least 42 patients (93-51) of this sicker group of patients (n=108) had lived to 36 months.
42/108= 38.89 % survival rate at 3 years.

If all these 42 patients are treatment, the Survival rate at 3 years = 50.6%.(42 of a group of 83 dcvax-l patients)

I repeat, if all these 42 patients are treatment, the Survival rate at 3 years = 50.6%.(of this final group of treatment patients)

No wonder Michael Bigger used the words Mind Blown!

Mind Blown! I'll let Dr. Rago explain all of this. I have a Physics degree not a Post Doc in Cancer Genetics from Johns Hopkins #GBM $NWBO

— Michael Bigger (@biggercapital) November 17, 2018